US BANCORP \DE\ - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 57 filers reported holding CIDARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$246,924
-16.6%
262,0720.0%0.00%
Q2 2023$296,141
-11.0%
262,0720.0%0.00%
-100.0%
Q1 2023$332,831
+67.9%
262,0720.0%0.00%
Q4 2022$198,205
+20.1%
262,0720.0%0.00%
Q3 2022$165,000
+28.9%
262,0720.0%0.00%
Q2 2022$128,000262,0720.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,627,670$1,533,5911.88%
5AM Venture Management, LLC 1,134,511$1,068,9360.31%
Nantahala Capital Management 2,538,406$2,391,6860.20%
BVF INC/IL 6,861,127$6,464,5540.17%
Monashee Investment Management LLC 369,099$347,7650.14%
West Family Investments, Inc. 368,910$347,5870.12%
JEPPSON WEALTH MANAGEMENT, LLC 137,560$129,6090.06%
XTX Topco Ltd 202,758$191,0390.03%
GSA CAPITAL PARTNERS LLP 136,974$1290.01%
Callan Capital, LLC 103,462$97,4820.01%
View complete list of CIDARA THERAPEUTICS INC shareholders